New York State Common Retirement Fund Sells 8,900 Shares of Colgate-Palmolive (NYSE:CL)

New York State Common Retirement Fund decreased its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 0.8% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,140,895 shares of the company's stock after selling 8,900 shares during the quarter. New York State Common Retirement Fund owned 0.14% of Colgate-Palmolive worth $103,719,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also modified their holdings of CL. Mcdonald Partners LLC lifted its stake in Colgate-Palmolive by 1.8% in the 4th quarter. Mcdonald Partners LLC now owns 9,996 shares of the company's stock worth $909,000 after acquiring an additional 172 shares in the last quarter. Kentucky Retirement Systems Insurance Trust Fund raised its stake in shares of Colgate-Palmolive by 28.7% during the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 31,126 shares of the company's stock worth $2,830,000 after purchasing an additional 6,934 shares in the last quarter. Ramsay Stattman Vela & Price Inc. raised its stake in shares of Colgate-Palmolive by 1.2% during the 4th quarter. Ramsay Stattman Vela & Price Inc. now owns 48,761 shares of the company's stock worth $4,433,000 after purchasing an additional 578 shares in the last quarter. Kestra Investment Management LLC increased its holdings in shares of Colgate-Palmolive by 57.6% during the 4th quarter. Kestra Investment Management LLC now owns 16,379 shares of the company's stock valued at $1,489,000 after acquiring an additional 5,984 shares during the last quarter. Finally, Braun Stacey Associates Inc. increased its holdings in shares of Colgate-Palmolive by 8.7% during the 4th quarter. Braun Stacey Associates Inc. now owns 250,787 shares of the company's stock valued at $22,799,000 after acquiring an additional 19,967 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock traded up $1.65 during midday trading on Friday, hitting $89.52. 2,212,567 shares of the company were exchanged, compared to its average volume of 4,803,892. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The firm has a market cap of $72.65 billion, a P/E ratio of 25.40, a PEG ratio of 4.18 and a beta of 0.44. Colgate-Palmolive has a 52 week low of $84.45 and a 52 week high of $109.30. The firm has a 50 day simple moving average of $89.02 and a 200-day simple moving average of $95.99.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the firm posted $0.87 earnings per share. Research analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were given a $0.50 dividend. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.23%. Colgate-Palmolive's payout ratio is 56.82%.

Analysts Set New Price Targets

CL has been the topic of a number of analyst reports. StockNews.com lowered Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Thursday, January 9th. JPMorgan Chase & Co. lowered their target price on Colgate-Palmolive from $103.00 to $97.00 and set an "overweight" rating on the stock in a report on Monday, February 3rd. Stifel Nicolaus lowered their target price on Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating on the stock in a report on Monday, February 3rd. Wells Fargo & Company lowered their target price on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating on the stock in a report on Tuesday, January 7th. Finally, Raymond James reaffirmed an "outperform" rating and issued a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $101.16.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.